Previous work has established the existence of a co-ordinate response in induction between Phase I
xenobiotic metabolism,
cytochrome P450 (CYP) and the multidrug resistance (MDR1) genes in hepatocytes and some
tumor cells. Further correlation was obtained between development of multidrug resistance in
cancer cells and a concomitant decrease in inducibility of CYP1A and
CYP3A drug metabolizing genes. In the present study, a human MDR1 promoter reporter gene construct was designed to investigate the reverse effect in which selected activators of the major CYP (1-3) genes were tested for potential inhibition of transcriptional activity of the MDR1 gene.
beta-naphthoflavone (BNF), a potent
CYP1A1 inducer, significantly (P<0.05) down-regulated MDR1 transcriptional activity
at 10 microM concentration, causing a 33-fold decrease relative to vector control values. Chemotherapeutic relevance of BNF's transcriptional down-regulation of MDR1 promoter activity was further demonstrated by its restoring 45.86%, and 79.34%
drug sensitivity to the resistant MCF-7/Adr cells
at 10- and 20 microM concentrations, respectively (P<0.05). A functional linkage between potent induction of the major CYP (1-3) genes and transcriptional down-regulation of MDR1 gene in
drug-resistant
tumor cells is hereby hypothesized.
Steroid and
xenobiotic nuclear receptor (SXR) is proposed to mediate the cross-talk between the two genes and to recruit potent CYP gene inducers as
co-repressor ligands in effecting its transcriptional down-regulation of MDR1 gene. Implications for the multidrug resistance phenomenon are discussed.